Pharmacology Seminar Series
| Date | Time | Speaker | Title | Location |
|---|---|---|---|---|
| January 19, 2022 | 12 pm | Agneta Nordberg, MD, PhD Division of Clinical Geriatrics Center for Alzheimer Research Karolinska Institute Stockholm, Sweden | "Reactive astrogliosis at different states of Alzheimer's disease - relation to other pathology biomarkers and clinical implications" | Zoom |
| January 26, 2022 | 12 pm | George M. Burslem, PhD Department of Biochemistry and Biophysics Perelman School of Medicine University of Pennsylvania | "Chemical approaches for modulating lysine post-translational modifications" | Zoom |
| February 9, 2022 | 12 pm | Nicole F. Liachko, PhD University of Washington Veterans Affairs Puget Sound Seattle, Washington | "TDP-43 in Alzheimer's disease: pathological correlates and insights from simple models" | Zoom |
| March 9, 2022 | 12 pm | Jamie Walker, MD, PhD Department of Pathology and Laboratory Medicine Brain Bank at Biggs Institute for Alzheimer & Neurodegenerative Institute UT Health San Antonio San Antonio, Texas | "Resistance to and resilience against Alzheimer's disease neuropathologic change" | Zoom |
| March 24, 2022 | 4:00pm | Inaugural Alan Frazer Lectureship Peter J. Turnbaugh, PhD Department of Microbiology & Immunology University of California, San Francisco San Francisco, California | "The tiny pharmacists within: how the microbiome impacts the treatment of human disease" | 409L (LSOM) |
| March 30, 2022 | 12 pm | 19th Annual Mariann Blum Memorial Lectureship in the Neurosciences Keri Martinowich, PhD Departments of Psychiatry and Behavioral Sciences and Neuroscience Johns Hopkins University School of Medicine Baltimore, Maryland | "Cell-type and spatially resolved molecular signatures in human brain disorders" | 409L (LSOM) |
| April 13, 2022 | 12 pm | NIH/NIDA T32-Training in Drug Abuse Research: Behavior and Neurobiology Postdoctoral Trainee Mini Symposium Lawrence M. Carey, IV, Ph.D. Laboratory of Charles France, Ph.D. Michael J. Wedemeyer, Ph.D. Laboratory of Kelly Berg, Ph.D. and Bill Clarke, Ph.D. Erin Wood, Ph.D. Laboratory of Nathalie Hill-Kapturczak, Ph.D., & Donald M. Dougherty, Ph.D. | "Carey: Phytocannabinoids as a treatment option for opioid use disorder Wedemeyer: Characterization of Buprenorphine Antagonism at Human Mu Opioid Receptors Wood: Heavy drinking behavior trajectory influence drink-refusal self-efficacy: Evidence from a Contingency Management study for DWI arrestees " | 444B (LSOM) |
| April 27, 2022 | 12 pm | Gang Huang, Ph.D. Department of Cell Systems and Anatomy Department of Pathology & Laboratory Medicine UT Health San Antonio San Antonio, Texas | "Mechanistic and therapeutic implications of pathobiological pseudohypoxia in Myelodysplastic syndroms" | 444B (LSOM) |
| May 11, 2022 | 12 pm | Co-sponsored by the Pain/Immunology Cluster of School of Dentistry Asaf Keller, PhD Department of Anatomy and Neurobiology University of Maryland School of Medicine Baltimore, Maryland | "Parabrachial nucleus: a nexus of affective pain" | 444B (LSOM) |
| May 18, 2022 | 12 pm | TBD | "TBD" | |
| May 25, 2022 | 12 pm | Jessica Ables, MD, PhD Department of Psychiatry Icahn School of Medicine at Mount Sinai New York, New York | "Effects of diabetes on reward circuitry" | 444B (LSOM) |
| June 1, 2022 | 12pm | Marco Pravetoni, PhD Department of Psychiatry and Behavioral Sciences Center for Medication Development for Substance Use Disorders University of Washington Seattle, Washington | "Vaccines and antibody-based strategies to treat opioid use disorders and overdose" | 444B (LSOM) |
| June 8, 2022 | 12pm | James D. Winkler, PhD Chief Scientific Officer at OnKure Therapeutics Head, Degrader Technologies, Frontier Medicines Boulder, Colorado | "Drug discovery with small molecule inhibitors and degraders - Challenges and successes" | 444B (LSOM) |